These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease. Hakeem A; Bhatti S; Karmali KN; Dillie KS; Cook JR; Xu J; Samad Z; Chang SM JACC Cardiovasc Imaging; 2010 Jul; 3(7):734-45. PubMed ID: 20633852 [TBL] [Abstract][Full Text] [Related]
13. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease]. Ravera M; Paoletti E Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Weiner DE; Tabatabai S; Tighiouart H; Elsayed E; Bansal N; Griffith J; Salem DN; Levey AS; Sarnak MJ Am J Kidney Dis; 2006 Sep; 48(3):392-401. PubMed ID: 16931212 [TBL] [Abstract][Full Text] [Related]
15. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications]. Ratto E; Leoncini G; Viazzi F; Pontremoli R G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events and death in Japanese patients with chronic kidney disease. Tanaka K; Watanabe T; Takeuchi A; Ohashi Y; Nitta K; Akizawa T; Matsuo S; Imai E; Makino H; Hishida A; Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399 [TBL] [Abstract][Full Text] [Related]
17. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)]. Minami J; Ishimitsu T; Sudo Y; Matsuoka H Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. White SL; Polkinghorne KR; Atkins RC; Chadban SJ Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414 [TBL] [Abstract][Full Text] [Related]
19. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031 [TBL] [Abstract][Full Text] [Related]
20. [Advances in detection, evaluation and management of chronic kidney disease]. Indridason OS; Thorsteinsdóttir I; Pálsson R Laeknabladid; 2007 Mar; 93(3):201-7. PubMed ID: 17341799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]